Author

David Zagzag

NYU Langone HealthORCID 0000-0002-2331-0613Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

David Zagzag1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Akiko KoideiD· 1 shared Alexis D. CorradoiD· 1 shared Alireza Khodadadi‐JamayraniD· 1 shared Aristotelis TsirigosiD· 1 shared Aryeh KormaniD· 1 shared Carsten HoffmanniD· 1 shared Cathryn Lapierre· 1 shared Christopher Lawson· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akiko KoideORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCell ReportsPeer-reviewedNov 1, 2023

The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability

Niklas Ravn-Boess, Nainita Roy, Takamitsu Hattori…·Dimitris G. Placantonakis

This study identifies CD97 as a targetable vulnerability in glioblastoma through its role in tumor metabolism and signaling, supported by transcriptomic, proteomic, and functional analyses.

28 citations

humanbulk RNA-seq

𝕏 PostBluesky